Prof Deepu Madduri presents data from the CARTITUDE-1 study during a press conference at the ASH 2019 meeting.
The study evaluated the response rate of JNJ-4528, a CAR-T Cell Therapy directed against B-Cell maturation antigen (BCMA), in multiple myeloma patients.
Read more about the study here.
Watch our interview with Prof Deepu Madduri here.